Back to Journals » Cancer Management and Research » Volume 13

RETRACTED ARTICLE: Regulatory Effect of miR497-5p–CCNE1 Axis in Triple-Negative Breast Cancer Cells and Its Predictive Value for Early Diagnosis

Authors Liu WW, Li WD, Zhang YJ, Zhang ML

Received 28 September 2020

Accepted for publication 5 November 2020

Published 18 January 2021 Volume 2021:13 Pages 439—447

DOI https://doi.org/10.2147/CMAR.S284277

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Eileen O'Reilly



This paper has been retracted.

Liu WW, Li WD, Zhang YJ, Zhang ML. Cancer Manag Res. 2021;13:439–447.

Following publication of the article, the authors raised concerns over the duplication of the two bar charts in Figure 5D. In addition, concerns were also raised about the duplication of images from Figure 2 with images from an unrelated article. Specifically,

  • The image for Figure 2C, MDA-MB-231, miR-497-5p-inhibitor, has been duplicated with the image for Figure 2d, A549, inhibit-NC, from Ge H, Wang L, Chen W, Wang L. Mechanism of miR-760 Reversing Lung Cancer Immune Escape by Downregulating IDO1 and Eliminating Regulatory T Cells Based on Mathematical Biology. Computational and Mathematical Methods in Medicine. 2022;2022: Article ID 2960773. https://doi.org/10.1155/2022/2960773.

When approached for an explanation, the authors were cooperative but were unable to provide a sufficient explanation for the image duplication or provide sufficient original data for their study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors agreed with this decision.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.